Formulation and Evaluation of Aceclofenac Liposomes
Patients who suffered from rheumatic disease and osteoarthritis are generally prescribed the non-steroidal anti-inflammatory drug (NSAIDs). Osteoarthritis is a common musculoskeletal disorder, which impairs body function and acts as an economic burden. Due to the repetitive use of ACE by oral route, it may cause gastrointestinal complications such as ulceration, bleeding, pain, perforation. To decrease the side effects of ACE, it is given by topical route in the form of ointment. This review highlights reducing gastrointestinal problems and promotes the safety and efficacy of the ACE. The Aceclofenac liposomes were prepared by the thin film hydration technique and evaluated by various methods such as in- vitro release study, % yield, drug entrapment efficiency, pH of the prepared formulation. The prepared system was also characterized by Fourier transform infra-red spectrophotometer to identify the drug- excipients interaction. The maximum entrapment efficiency of liposomes was found to be 90%. The main aim of this study was to develop and characterized a vesicular drug carrier system for topical delivery of Aceclofenac to overcome the problem related with oral route.
Keywords: Liposomes, Aceclofenac, topical delivery, transdermal delivery, rheumatic disease and osteoarthritis
2. Liu Q, Boyd BJ. Liposomes in biosensors. Analyst, 2012; in press. 2021.
3. Allison, Anthony C., and Gregory. Gregoriadis. Liposomes in Biological Systems. Chichester: John Wiley & Sons, Ltd., 1980. Print.
4. Deamer D. From "Banghasomes" to liposomes: A memoir of Alec Bangham, 1921-2010. The FASEB Journal. 2010; 24(5):1308-1310. https://doi.org/10.1096/fj.10-0503
5. Chioma E. Formulation and Evaluation of Etodolac Niosomes by Modified Ether Injection Technique. Universal Journal of Pharmaceutical Research. 2016; 1(1):1-6. https://doi.org/10.22270/ujpr.v1i1.R1
6. Anwar W, Dawaba HM, Afouna MI, Samy AM. Screening study forformulation variables in preparation and characterization of candesartan cilexetil loaded nanostructured lipid carriers. Universal Journal of Pharmaceutical Research 2019; 4(6):8-19. https://doi.org/10.22270/ujpr.v4i6.330
7. Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare O. Design, Development and Optimization of Nimesulide-Loaded Liposomal Systems for Topical Application. Current Drug Delivery. 2005; 2(2):143-153. https://doi.org/10.2174/1567201053585985
8. Andhale A Varsha, Patil Priyanka R, Dhas Ahuja U, Chauhan Priyanka D, Desai Seema V, liposomes an emerging tool in drug carrier system. International journal of pharmacy and technology. 2016; 8(1): 10988- 11011.
9. Nwobodo NN, Adamude FA, Dingwoke EJ, Ubhenin A. Formulation and evaluation of elastic liposomes of decitabine prepared by rotary evaporation method. Universal Journal of Pharmaceutical Research 2019; 4(3):1-5. https://doi.org/10.22270/ujpr.v4i3.267
10. Dua J.S. et. al. Liposomes: Methods of preparation and application: International Journal of Pharmaceutical studies and research. 2012; 4:14-20.
11. Mishra H, Chauhan V, Kumar K, Teotia D. A comprehensive review on Liposomes: a novel drug delivery system. Journal of Drug Delivery and Therapeutics. 2018; 8(6):400-404. https://doi.org/10.22270/jddt.v8i6.2071
12. John DF, Yunus AA, Chigbo UJ, Paul US, Ikenna E. Tolnaftate loaded liposomes-design, and in-vitro evaluation. Universal Journal of Pharmaceutical Research 2016; 1(2): 29-31. https://doi.org/10.22270/ujpr.v1i2.R6
13. Subhash Chandran M.p, Prasbh G.R Jaghatha T, Aswathy B.S, Remya S.B. An overview on Liposomal drug delivery system. International Journal of Pharmaceutical and phytopharmcological research. 2019; 9(2):61-69.
14. Elsaied EH, Dawaba HM, Ibrahim ESA, Afouna MI. Effect of pegylated edge activator on Span 60 based nanovesicles: comparison between Myrj 52 and Myrj 59. Universal Journal of Pharmaceutical Research 2019; 4(4):1-8. https://doi.org/10.22270/ujpr.v4i4.290
15. Nagasany Venkatesh Dhandapani. Liposomes as Novel drug delivery system: A Comprehensive Review, Int J, Res. Pharm Sci, 4(2):187-193.
16. Kulkarni K, Priyanka R, Yadav JD, Vaidya KA. Liposomes a novel drug delivery system. International Journal of Current Pharmaceutical Research. 2011; 3(2):10-18.
17. Sharma A. Liposomes in drug delivery: Progress and limitations. International Journal of Pharmaceutics. 1997; 154(2):123-140. https://doi.org/10.1016/S0378-5173(97)00135-X
18. Shaheen SM, Ahmed FRS, Hossen MN, Ahmed M, Amran MS, Anwar-UL-Islam M, Liposome as a Carrier for Advanced Drug Delivery. Pakistan Journal of Biological Sciences. 2006; 9(6):1181-1191. https://doi.org/10.3923/pjbs.2006.1181.1191
19. Ugochukwu AE, Nnedimkpa OJ, Rita NO. Preparation and characterization of Tolterodine tartrate proniosomes. Universal Journal of Pharmaceutical Research 2017; 2(2):1-3. https://doi.org/10.22270/ujpr.v2i2.R1
20. Mishra H, Kaur G, Kumar K, Teotia D. Formulation and evaluation of liposomes of Indomethacin. Journal of advanced scientific research, 2019; 10(4):180-185.
21. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo S, Zarghami N, Hanifehpour Y et al. Liposome: classification, preparation, and applications. Nanoscale Research Letters. 2013; 8(1). https://doi.org/10.1186/1556-276X-8-102
22. Mathur P, Mathur CK, Mathur K. Oral drug delivery of insulin in diabetes mellitus: an attractive alternate to overcome invasive route. Universal Journal of Pharmaceutical Research 2018; 3(6): 45-48. https://doi.org/10.22270/ujpr.v3i6.221
23. Jadhav M, Gaikwad R, Kshirsagar N, Nagarsenker M, Samad A. Formulation and evaluation of long circulating liposomal Amphotericin B: A scinti-kinetic study using99mTc in BALB/C mice. Indian Journal of Pharmaceutical Sciences. 2011; 73(1):57. https://doi.org/10.4103/0250-474X.89757
24. Riaz Mohammad. Liposomes Preparation Methods. Pakistan Journal of Pharmaceutical Sciences.1991; 19(1):65-77.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).